• Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=24732172).
  

PubMed=6386801; DOI=10.1016/S0021-9258(18)90807-0
Bumol T.F., Walker L.E., Reisfeld R.A.
Biosynthetic studies of proteoglycans in human melanoma cells with a monoclonal antibody to a core glycoprotein of chondroitin sulfate proteoglycans.
J. Biol. Chem. 259:12733-12741(1984)

PubMed=2447074; DOI=10.1016/S0021-9258(18)45436-1
Cheresh D.A., Spiro R.C.
Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factor.
J. Biol. Chem. 262:17703-17711(1987)

PubMed=1376331; DOI=10.1172/JCI115811; PMCID=PMC295910
Felding-Habermann B., Mueller B.M., Romerdahl C.A., Cheresh D.A.
Involvement of integrin alpha V gene expression in human melanoma tumorigenicity.
J. Clin. Invest. 89:2018-2022(1992)

PubMed=15592718; DOI=10.1007/s00262-004-0561-5; PMCID=PMC11032966
Rodriguez T., Mendez R., Roberts C.H., Ruiz-Cabello Osuna F., Dodi I.A., Lopez-Nevot M.A., Paco L., Maleno I., Marsh S.G.E., Pawelec G., Garrido F.
High frequency of homozygosity of the HLA region in melanoma cell lines reveals a pattern compatible with extensive loss of heterozygosity.
Cancer Immunol. Immunother. 54:141-148(2005)

PubMed=24732172; DOI=10.18632/oncotarget.1878; PMCID=PMC4039118
Sabbatino F., Wang Y.-Y., Wang X.-H., Flaherty K.T., Yu L., Pepin D., Scognamiglio G., Pepe S., Kirkwood J.M., Cooper Z.A., Frederick D.T., Wargo J.A., Ferrone S., Ferrone C.R.
PDGFRalpha up-regulation mediated by sonic hedgehog pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation.
Oncotarget 5:1926-1941(2014)